Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home
31 items matching your search terms.
Filter the results.
Item type














New items since



Sort by relevance · date (newest first) · alphabetically
Dees and Hayes named co-leaders of UNC Lineberger Clinical Research Program
by William Shawn Davis published May 09, 2013 — filed under:
Claire Dees, MD, and Neil Hayes, MD, MPH, have been appointed as co-leaders of the Clinical Research Program at UNC Lineberger Comprehensive Cancer Center. Dr. Dees and Hayes have extensive and complementary expertise in translational and clinical research. As co-leaders of the Clinical Research Program, they will help plan the efforts of UNC Lineberger’s physician researchers to move discoveries into innovative trials of new therapeutic approaches.
Located in Old top news stories
IMRT may not be more effective than older radiation techniques after prostatectomy
by William Shawn Davis published May 20, 2013 last modified May 21, 2013 08:18 AM — filed under:
Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from the University of North Carolina suggests that the therapy may not be more effective than older, less expensive forms of radiation therapy in patients who have had a prostatectomy.
Located in Old top news stories
UNC Lineberger members present at 2013 ASCO Annual Meeting
by William Shawn Davis (wishda) published Jun 05, 2013 last modified Jun 06, 2013 09:06 AM — filed under:
More than 15 members and associates of the UNC Lineberger Comprehensive Cancer Center presented their work to the attendees at the 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Located in News
2013 UCRF Innovation Awards announced
by William Shawn Davis (wishda) published Jul 23, 2013 last modified Aug 06, 2013 03:04 PM — filed under:
UCRF Competitive Grants Program 2013 Innovation Awards were chosen from 51 applications. The awards provided $1,180,000 to support research among the six winners.
Located in News
Inhibiting Macrophage MerTK Signaling Creates an Innate Immune Response Against Cancer
by Megan Fazekas-King (fazekask) published Jul 08, 2013 last modified Jul 08, 2013 01:01 PM — filed under:
The tyrosine kinase MerTK plays a prominent role in the body’s immune response. MerTK signaling helps “calm” the body’s first line of immunity, the macrophage, while it performs the routine duties - clearing cells that die and healing damaged tissue.
Located in Old top news stories
IMRT may not be more effective than older radiation techniques after prostatectomy
by William Shawn Davis (wishda) published May 28, 2013 — filed under:
Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from the University of North Carolina suggests that the therapy may not be more effective than older, less expensive forms of radiation therapy in patients who have had a prostatectomy.
Located in News
Smith - Worldwide cervical cancer prevention initiative announced at Women Deliver Conference in Malaysia
by William Shawn Davis (wishda) published May 28, 2013 last modified May 28, 2013 01:54 PM — filed under:
Cervical cancer kills an estimated 275,000 women each year, and most of these deaths could be prevented with prophylactic HPV vaccination, routine cervical cancer screening and continuity to treatment. At the Women Deliver Conference in Kuala Lumpur, Malaysia, delegates and experts from around the world announced a global call to action to combat this preventable disease through collaboration with and information sharing by the world’s governments and health agencies on May 27, 2013.
Located in News
Survey of adolescent males and their parents shows low HPV vaccination rates
by William Shawn Davis published Aug 28, 2013 last modified Sep 04, 2013 03:53 PM — filed under:
Encouraging physicians to recommend human papillomavirus (HPV) vaccine to adolescent boys and their parents - and educating the boys and their families about the importance of receiving the vaccine - are essential to reducing the cancers this virus can cause.
Located in News
UNC-Malawi cancer pathology laboratory is a model for Sub-Saharan Africa
by William Shawn Davis (wishda) published Aug 02, 2013 last modified Aug 08, 2013 10:13 AM — filed under:
Since 2011, the University of North Carolina has partnered with the government of Malawi to establish a pathology laboratory in the nation’s capital, building on an existing decades-long collaboration. The laboratory has provided an invaluable service to patients and has also built capacity at a national teaching hospital, according to an analysis of the first 20 months of operation published August 7 online by PLOS ONE.
Located in Old top news stories
UNC Lineberger announces Marci Kramish Campbell Dissertation Award recipients
by William Shawn Davis (wishda) published Jul 17, 2013 last modified Jul 22, 2013 04:38 PM — filed under:
Shellie Ellis, MA, and Shelley Golden, PhD, of the Gillings School of Global Public Health are the 2013 recipients of the Marci Kramish Campbell Dissertation Award, a competitive $5,000 award to recognize excellence in dissertation research focused on cancer and the population sciences.
Located in News